You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
No AccessJournal of UrologyAdult Urology1 Sep 2011

Selective Arterial Embolization of Angiomyolipomas: A Comparison of Smaller and Larger Embolic Agents

    View All Author Information


    Selective transarterial embolization for renal angiomyolipomas is effective in preventing or limiting hemorrhage and preserving normal parenchyma. Data are insufficient regarding the safety and efficacy of embolic agents. We compared transarterial embolization of angiomyolipomas using embolic agents of different sizes.

    Materials and Methods:

    We performed a retrospective review of all transarterial angiomyolipoma embolizations from 1999 to 2010, and evaluated demographics, procedural data, embolization response and outcomes comparing smaller (less than 150 microns) and larger (more than 150 microns) embolic agents.


    Overall 48 patients underwent 66 embolization procedures for 72 angiomyolipomas. Smaller agents were used more commonly (58%). Age, gender, indications, pre-embolization angiomyolipoma size and prevalence of tuberous sclerosis were similar between the groups. Angiomyolipomas decreased a mean ± SD 25% ± 18% after embolization with no differences between the groups (p = 0.24). There were 10 angiomyolipomas that required 14 repeat embolizations (median 14 months). Repeat embolization of the same mass was almost sixfold more likely in those embolized with smaller agents (OR 5.88, 95% CI 1.64–20.8, p = 0.002). Complications were similar between the groups, although 2 of 3 patients with acute respiratory distress underwent embolization with smaller agents. Patients with tuberous sclerosis had similar angiomyolipoma size, decrease in angiomyolipoma size, followup, complications and need for repeat embolization. Practice patterns changed regarding embolization agent size during the study period.


    Angioembolization with larger embolic agents is associated with higher long-term efficacy compared to smaller agents. Due to concerns for serious pulmonary complications, we no longer use agents smaller than 150 microns. Prospective studies are necessary to evaluate the optimal embolization technique to achieve durable outcomes without increasing patient morbidity.


    • 1 : Contemporary diagnosis and management of renal angiomyolipoma. J Urol2002; 168: 1315. LinkGoogle Scholar
    • 2 : The management of renal angiomyolipoma. J Urol1986; 135: 1121. LinkGoogle Scholar
    • 3 : Management of renal angiomyolipomas associated with tuberous sclerosis complex. J Urol2004; 171: 102. LinkGoogle Scholar
    • 4 : Management of hemorrhage secondary to renal angiomyolipoma with selective arterial embolization. J Urol1977; 117: 122. LinkGoogle Scholar
    • 5 : Management of renal angiomyolipoma by selective arterial embolization. Urol Int1998; 60: 113. Google Scholar
    • 6 : Successful embolization of symptomatic renal artery aneurysm in solitary kidney. Urology2005; 65: 795. Google Scholar
    • 7 : Renal angiomyolipoma: long-term results after arterial embolization. J Vasc Interv Radiol2005; 16: 45. Google Scholar
    • 8 : Renal angiomyolipomas: long-term follow-up of embolization for acute hemorrhage. Can Assoc Radiol J1997; 48: 191. Google Scholar
    • 9 : Renal angiomyolipoma: embolotherapy with a mixture of alcohol and iodized oil. J Vasc Interv Radiol1998; 9: 255. Google Scholar
    • 10 : Fatal pulmonary complications after arterial embolization with 40–120- micro m tris-acryl gelatin microspheres. J Vasc Interv Radiol2004; 15: 197. Google Scholar
    • 11 : Management of renal angiomyolipoma: analysis of 15 cases. Eur Urol1998; 33: 572. Crossref, MedlineGoogle Scholar
    • 12 : Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms. Urology2008; 72: 1077. Google Scholar
    • 13 : Contemporary experience in the management of angiomyolipoma. J Endourol2010; 24: 1883. Google Scholar
    • 14 : Long-term follow-up of the treatment of renal angiomyolipomas after selective arterial embolization with alcohol. BJU Int2009; 105: 390. Google Scholar
    • 15 : Long-term outcome of transcatheter embolization of renal angiomyolipomas due to tuberous sclerosis complex. J Urol2005; 174: 1764. LinkGoogle Scholar
    • 16 : Embolization of the internal iliac artery: still more to learn. J Vasc Interv Radiol2000; 11: 543. Google Scholar
    • 17 : Embolization of renal angiomyolipomas: short-term and long-term outcomes, complications, and tumor shrinkage. Cardiovasc Intervent Radiol2009; 32: 1171. Google Scholar
    • 18 : Ethanol and polyvinyl alcohol mixture for transcatheter embolization of renal angiomyolipoma. AJR Am J Roentgenol2006; 187: 762. Google Scholar
    • 19 : Partition of calibrated tris-acryl gelatin microspheres in the arterial vasculature of embolized nasopharyngeal angiofibromas and paragangliomas. J Vasc Interv Radiol2005; 16: 507. Google Scholar
    • 20 : Arterial distribution of calibrated tris-acryl gelatin and polyvinyl alcohol microspheres in a sheep kidney model. Invest Radiol2006; 41: 8. Google Scholar
    • 21 : Transcatheter arterial embolization in patients with kidney diseases: an overview of the technical aspects and clinical indications. Korean J Radiol2010; 11: 257. Google Scholar
    • 22 : Fatal pulmonary embolism after embolization of a hepatocellular carcinoma using microspheres. Radiologia2008; 50: 248. Google Scholar
    • 23 : Bland embolization in patients with unresectable hepatocellular carcinoma using precise, tightly size-calibrated, anti-inflammatory microparticles: first clinical experience and one-year follow-up. Cardiovasc Intervent Radiol2009; 33: 552. Google Scholar